Home > Compound List > Product Information
KR-62436 hydrate_Molecular_structure_CAS_761414-79-3(freebase))
Click picture or here to close

KR-62436 hydrate

Catalog No. K4264 Name Sigma Aldrich
CAS Number 761414-79-3(freebase) Website http://www.sigmaaldrich.com
M. F. C14H19Cl2N7O2 Telephone 1-800-521-8956
M. W. 388.25236 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 153941

SYNONYMS

IUPAC name
6-[(2-{[2-(5-cyano-4,5-dihydro-1H-pyrazol-1-yl)-2-oxoethyl]amino}ethyl)amino]pyridine-3-carbonitrile hydrate dihydrochloride
IUPAC Traditional name
6-[(2-{[2-(5-cyano-4,5-dihydropyrazol-1-yl)-2-oxoethyl]amino}ethyl)amino]pyridine-3-carbonitrile hydrate dihydrochloride
Synonyms
6-{2-[(5-Cyano-4,5-dihydropyrazol-1-yl)-2-oxoethylamino]ethylamino}nicotinonitrile dihydrochloride hydrate

DATABASE IDS

CAS Number 761414-79-3(freebase)
MDL Number MFCD17215675
PubChem SID 24724521

PROPERTIES

Empirical Formula (Hill Notation) C14H15N7O·2HCl · xH2O
Purity ≥98% (HPLC)
Apperance light tan solid
Solubility DMSO: >10 mg/mL
Solubility H2O: >5 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Risk Statements 22
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
KR-62436 is a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV). DPP-IV is a serine protease which inactivates glucagon-like peptide (GLP-1); IC50 0.1-0.8 μM; GLP-1 is a potent stimulus for insulin secretion and inducer of satiety after food intake, but it has a very short action (1 min) because it is rapidly degraded by DPP-IV; blocking DPP-IV increases GLP-1 action and increases plasma insulin levels; DPP-IV inhibitors and KR-62436 have clinical potential as anti-diabetic agents
Description (简体中文)
Biochem/physiol Actions
KR-62436 is a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV). DPP-IV is a serine protease which inactivates glucagon-like peptide (GLP-1); IC50 0.1-0.8 μM; GLP-1 is a potent stimulus for insulin secretion and inducer of satiety after food intake, but it has a very short action (1 min) because it is rapidly degraded by DPP-IV; blocking DPP-IV increases GLP-1 action and increases plasma insulin levels; DPP-IV inhibitors and KR-62436 have clinical potential as anti-diabetic agents

REFERENCES